Regeneron Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of REGN for the last quarter is 3.15 B USD, and it's 8.42% lower compared to the previous quarter. The net income of Q1 24 is 722.00 M USD.